Health care providers registered with the Drug Enforcement Administration must use the new single-sheet form to order schedule I and II controlled substances, effective Oct. 30, the agency announced Monday. DEA began transitioning to the new form two years ago under a 2019 final rule. In July, DEA also published a direct final rule to clarify that either the purchaser or the supplier may enter a supplier’s DEA registration number on the new single-sheet form.

Related News Articles

Headline
The Department of Health and Human Services today proposed to withdraw a rule finalized in January that requires the agency to periodically assess each…
Headline
The AHA yesterday urged the Centers for Medicare & Medicaid Services to conduct the necessary oversight and enforcement of the No Surprises Act to…
Headline
The AHA, joined by the Federation of American Hospitals, Michigan Health & Hospital Association, Kentucky Hospital Association, Ohio Hospital Association…
Headline
The U.S. Chamber of Commerce and 21 other organizations, including the AHA, today urged Congress to maintain the current legal and regulatory framework for…
Blog
Post-acute care (PAC) providers continue to play a central role in COVID-19 response and recovery. In particular, providers in COVID-19 hotspots have been…
Headline
As strongly advocated by the AHA, the Centers for Medicare & Medicaid Services today announced that it is rescinding prior audit denials for hospitals that…